About this Session:
Despite women constituting 50% of the population, a mere 1% of healthcare research and innovation investment is directed towards female-specific conditions beyond oncology. There is the clear societal need and sound business case for more health services and solutions for the specific health needs of women from menstruation to menopause to vaginal health. As most investment firms remain male-dominated, pitching solutions like a smart menstrual pad to a room of men is not that simple. Leaders have not let that stop them and are proving that investing in women’s health is not just imperative for improving the lives of women globally, but it also presents tremendous opportunities for value creation. Hear us roar!